Nicergoline, a drug used for age-dependent cognitive impairment, protects cultured neurons against β-amyloid toxicity
- 1 June 2005
- journal article
- Published by Elsevier in Brain Research
- Vol. 1047 (1) , 30-37
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Induction of Dickkopf-1, a Negative Modulator of the Wnt Pathway, Is Associated with Neuronal Degeneration in Alzheimer's BrainThe Journal of Neuroscience, 2004
- Alpha-1B adrenergic receptor knockout mice are protected against methamphetamine toxicityJournal of Neurochemistry, 2004
- Erratic expression of DNA polymerases by β‐amyloid causes neuronal deathThe FASEB Journal, 2002
- Nicergoline stimulates protein kinase C mediated α-secretase processing of the amyloid precursor protein in cultured human neuroblastoma SH-SY5Y cellsNeurochemistry International, 1999
- Neuroprotection by Glial Metabotropic Glutamate Receptors Is Mediated by Transforming Growth Factor-βJournal of Neuroscience, 1998
- Nicergoline and its metabolite induce translocation of PKC isoforms in selective rat brain areasNeuroscience Research Communications, 1998
- Modulation of phosphoinositide turnover by chronic nicergoline in rat brainNeuroscience Letters, 1996
- Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation.Proceedings of the National Academy of Sciences, 1995
- Modulation of hippocampal ACh release by chronic nicergoline treatment in freely moving young and aged ratsNeuroscience Letters, 1995
- Studies on the metabolism of ergoline derivativesBiochemical Pharmacology, 1972